UNH

SEC source: 0000731766-07-000059 · edgardoc.xml · nonDerivative · entry 3

RYAN ROBERT L · CIK 0001024354 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,120

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000731766-07-000059 · edgardoc.xml · nonDerivative · entry 2

RYAN ROBERT L · CIK 0001024354 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,120

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000731766-07-000048 · edgardoc.xml · nonDerivative · entry 1

WILENSKY GAIL R · CIK 0001018538 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,090

SEC source: 0001181431-07-027809 · rrd156068.xml · nonDerivative · entry 3

RANGEN ERIC S · CIK 0001175737 · Sr VP & Chief Acctg Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · Custodial Account for child

Disclosed balance after: 20

SEC source: 0001181431-07-027809 · rrd156068.xml · nonDerivative · entry 2

RANGEN ERIC S · CIK 0001175737 · Sr VP & Chief Acctg Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · Custodial Account for child

Disclosed balance after: 20

SEC source: 0001181431-07-027809 · rrd156068.xml · nonDerivative · entry 1

RANGEN ERIC S · CIK 0001175737 · Sr VP & Chief Acctg Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000

SEC source: 0000731766-07-000049 · edgardoc.xml · derivative · entry 2

LEATHERDALE DOUGLAS W · CIK 0001024367 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 32,000 shares

Expires 2007-05-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000731766-07-000049 · edgardoc.xml · nonDerivative · entry 1

LEATHERDALE DOUGLAS W · CIK 0001024367 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 938,365

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000731766-07-000041 · edgardoc.xml · derivative · entry 3

MUNDINGER MARY ONEIL · CIK 0001179980 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,000 shares

Expires 2007-05-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option is exercisable in three equal annual installments beginning 5/14/98.

SEC source: 0000731766-07-000041 · edgardoc.xml · nonDerivative · entry 2

MUNDINGER MARY ONEIL · CIK 0001179980 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,000

SEC source: 0000731766-07-000041 · edgardoc.xml · nonDerivative · entry 1

MUNDINGER MARY ONEIL · CIK 0001179980 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000731766-07-000042 · edgardoc.xml · nonDerivative · entry 1

BURKE RICHARD T · CIK 0000905023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,836,300

F1 · price: Reflects the average per share price of 100,000 shares of common stock of UnitedHealth Group Incorporated sold by the reporting person in multiple transactions on April 20, 2007, with sales prices ranging from $52.50 to $53.21 per share. Mr. Burke has had no purchase transactions within the last six months.

SEC source: 0000731766-07-000043 · edgardoc.xml · derivative · entry 12

KEAN THOMAS H · CIK 0001176475 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 32,000 shares

Expires 2007-05-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000731766-07-000043 · edgardoc.xml · nonDerivative · entry 11

KEAN THOMAS H · CIK 0001176475 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,000

SEC source: 0000731766-07-000043 · edgardoc.xml · nonDerivative · entry 10

KEAN THOMAS H · CIK 0001176475 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,800

SEC source: 0000731766-07-000043 · edgardoc.xml · nonDerivative · entry 9

KEAN THOMAS H · CIK 0001176475 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,100

SEC source: 0000731766-07-000043 · edgardoc.xml · nonDerivative · entry 8

KEAN THOMAS H · CIK 0001176475 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,600

SEC source: 0000731766-07-000043 · edgardoc.xml · nonDerivative · entry 7

KEAN THOMAS H · CIK 0001176475 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,000

SEC source: 0000731766-07-000043 · edgardoc.xml · nonDerivative · entry 6

KEAN THOMAS H · CIK 0001176475 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,500

SEC source: 0000731766-07-000043 · edgardoc.xml · nonDerivative · entry 5

KEAN THOMAS H · CIK 0001176475 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,800

SEC source: 0000731766-07-000043 · edgardoc.xml · nonDerivative · entry 4

KEAN THOMAS H · CIK 0001176475 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,700

SEC source: 0000731766-07-000043 · edgardoc.xml · nonDerivative · entry 3

KEAN THOMAS H · CIK 0001176475 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,400

SEC source: 0000731766-07-000043 · edgardoc.xml · nonDerivative · entry 2

KEAN THOMAS H · CIK 0001176475 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,500

SEC source: 0000731766-07-000043 · edgardoc.xml · nonDerivative · entry 1

KEAN THOMAS H · CIK 0001176475 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000731766-07-000045 · edgardoc.xml · derivative · entry 3

JOHNSON JAMES A /DC/ · CIK 0001126949 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 0

Underlying: Common Stock · 32,000 shares

Expires 2007-05-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000731766-07-000045 · edgardoc.xml · nonDerivative · entry 2

JOHNSON JAMES A /DC/ · CIK 0001126949 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 51,200

F1 · ownership.nature: These shares are held in a trust for the benefit of the reporting person's child. The reporting person's spouse is a trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

SEC source: 0000731766-07-000045 · edgardoc.xml · nonDerivative · entry 1

JOHNSON JAMES A /DC/ · CIK 0001126949 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 83,200

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001181431-07-026259 · rrd155049.xml · derivative · entry 4

Mikan George Lawrence III · CIK 0001381037 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2012-01-07

F1 · date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · kind: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · price: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · derivative.exercise_date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

SEC source: 0001181431-07-026259 · rrd155049.xml · derivative · entry 3

Mikan George Lawrence III · CIK 0001381037 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common Stock · 50,000 shares

Expires 2012-01-07

F1 · date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · kind: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · price: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · derivative.exercise_date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

SEC source: 0001181431-07-026259 · rrd155049.xml · derivative · entry 2

Mikan George Lawrence III · CIK 0001381037 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2011-06-01

F1 · date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · kind: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · price: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · derivative.exercise_date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

SEC source: 0001181431-07-026259 · rrd155049.xml · derivative · entry 1

Mikan George Lawrence III · CIK 0001381037 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 10,000 shares

Expires 2011-06-01

F1 · date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · kind: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · price: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · derivative.exercise_date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

SEC source: 0000731766-07-000034 · edgardoc.xml · derivative · entry 2

DARRETTA ROBERT J · CIK 0001188999 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Stock · 12,500 shares

Expires 2017-04-17

F1 · derivative.exercise_date: The option is exercisable in four equal annual installments beginning 4/17/2008.

SEC source: 0000731766-07-000034 · edgardoc.xml · nonDerivative · entry 1

DARRETTA ROBERT J · CIK 0001188999 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,125

SEC source: 0001181431-07-026258 · rrd155058.xml · derivative · entry 6

Burke Forrest Gregory · CIK 0001379886 · Acting General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2015-10-31

F1 · date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · kind: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · price: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · derivative.exercise_date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

SEC source: 0001181431-07-026258 · rrd155058.xml · derivative · entry 5

Burke Forrest Gregory · CIK 0001379886 · Acting General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,000 shares

Expires 2015-10-31

F1 · date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · kind: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · price: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · derivative.exercise_date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

SEC source: 0001181431-07-026258 · rrd155058.xml · derivative · entry 4

Burke Forrest Gregory · CIK 0001379886 · Acting General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2015-05-02

F1 · date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · kind: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · price: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · derivative.exercise_date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

SEC source: 0001181431-07-026258 · rrd155058.xml · derivative · entry 3

Burke Forrest Gregory · CIK 0001379886 · Acting General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 30,000 shares

Expires 2015-05-02

F1 · date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · kind: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · price: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · derivative.exercise_date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

SEC source: 0001181431-07-026258 · rrd155058.xml · derivative · entry 2

Burke Forrest Gregory · CIK 0001379886 · Acting General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,000

Underlying: Common Stock · 90,000 shares

Expires 2015-01-04

F1 · date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · kind: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · price: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · derivative.exercise_date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

SEC source: 0001181431-07-026258 · rrd155058.xml · derivative · entry 1

Burke Forrest Gregory · CIK 0001379886 · Acting General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 90,000 shares

Expires 2015-01-04

F1 · date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · kind: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · price: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · derivative.exercise_date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

SEC source: 0001181431-07-026259 · rrd155049.xml · derivative · entry 18

Mikan George Lawrence III · CIK 0001381037 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2015-10-31

F1 · date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · kind: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · price: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · derivative.exercise_date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

SEC source: 0001181431-07-026259 · rrd155049.xml · derivative · entry 17

Mikan George Lawrence III · CIK 0001381037 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 45,000 shares

Expires 2015-10-31

F1 · date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · kind: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · price: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · derivative.exercise_date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

SEC source: 0001181431-07-026259 · rrd155049.xml · derivative · entry 16

Mikan George Lawrence III · CIK 0001381037 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2015-05-02

F1 · date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · kind: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · price: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · derivative.exercise_date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

SEC source: 0001181431-07-026259 · rrd155049.xml · derivative · entry 15

Mikan George Lawrence III · CIK 0001381037 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 100,000 shares

Expires 2015-05-02

F1 · date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · kind: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · price: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · derivative.exercise_date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

SEC source: 0001181431-07-026259 · rrd155049.xml · derivative · entry 14

Mikan George Lawrence III · CIK 0001381037 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 190,000

Underlying: Common Stock · 190,000 shares

Expires 2014-11-04

F1 · date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · kind: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · price: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · derivative.exercise_date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

SEC source: 0001181431-07-026259 · rrd155049.xml · derivative · entry 13

Mikan George Lawrence III · CIK 0001381037 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 190,000 shares

Expires 2014-11-04

F1 · date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · kind: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · price: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · derivative.exercise_date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

SEC source: 0001181431-07-026259 · rrd155049.xml · derivative · entry 12

Mikan George Lawrence III · CIK 0001381037 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2014-05-10

F1 · date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · kind: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · price: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · derivative.exercise_date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

SEC source: 0001181431-07-026259 · rrd155049.xml · derivative · entry 11

Mikan George Lawrence III · CIK 0001381037 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 150,000 shares

Expires 2014-05-10

F1 · date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · kind: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · price: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · derivative.exercise_date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

SEC source: 0001181431-07-026259 · rrd155049.xml · derivative · entry 10

Mikan George Lawrence III · CIK 0001381037 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,500

Underlying: Common Stock · 52,500 shares

Expires 2013-10-28

F1 · date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · kind: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · price: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · derivative.exercise_date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

SEC source: 0001181431-07-026259 · rrd155049.xml · derivative · entry 9

Mikan George Lawrence III · CIK 0001381037 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,500

Underlying: Common Stock · 52,500 shares

Expires 2013-10-28

F1 · date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · kind: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · price: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · derivative.exercise_date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

SEC source: 0001181431-07-026259 · rrd155049.xml · derivative · entry 8

Mikan George Lawrence III · CIK 0001381037 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2013-02-12

F1 · date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · kind: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · price: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · derivative.exercise_date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Mikan prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.